Insight Molecular Diagnostics Inc
NASDAQ:IMDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
|
US |
|
C
|
Clio Cosmetics Co Ltd
KOSDAQ:237880
|
KR |
|
Joyas International Holdings Ltd
SGX:E9L
|
HK |
|
D
|
Dow Inc
F:2OY
|
US |
|
Legrand SA
PAR:LR
|
FR |
|
N
|
NetApp Inc
DUS:NTA
|
US |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
Sartorius AG
F:SRT3
|
DE |
|
Wheaton Precious Metals Corp
TSX:WPM
|
CA |
|
Roche Holding AG
OTC:RHHBF
|
CH |
|
Kirloskar Ferrous Industries Ltd
NSE:KIRLFER
|
IN |
|
Gabetti Property Solutions SpA
MIL:GAB
|
IT |
|
Singapore Post Ltd
OTC:SPSTY
|
SG |
|
A
|
Ares Capital Corp
SWB:9A2
|
US |
Bankruptcy Probability
Insight Molecular Diagnostics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Insight Molecular Diagnostics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
|
113.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Insight Molecular Diagnostics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Insight Molecular Diagnostics Inc has total debt of 242k USD. This includes both short-term (0 USD) and long-term (242k USD) debt.
You can find a full breakdown on its Balance Sheet.